SCHEMBL1334779

SCHEMBL1334779

CCCCCCCCC(CCCCO)CCCCCCC

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.68
ALDH1A1 P00352 3/20 0.68
HSD17B10 Q99714 1/20 0.68
MEN1 O00255 1/20 0.68
KMT2A Q03164 1/20 0.68
TSHR P16473 1/20 0.68
SMN1; SMN2 Q16637 1/20 0.63
CYP2D6 P10635 2/20 0.45
SPHK1 Q9NYA1 2/20 0.45
GMNN O75496 1/20 0.45
POLB P06746 1/20 0.45
THPO P40225 1/20 0.45
MTOR P42345 1/20 0.45
BLM P54132 1/20 0.45
KDM4E B2RXH2 1/20 0.45
TP53 P04637 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
MAPT P10636 1/20 0.45
CETP P11597 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18723000 1.00 LMNA (0.68) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL15478669 1.00 LMNA (0.68) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL8740048 1.00 LMNA (0.68) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL7106617 1.00 LMNA (0.68) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL23855449 1.00 LMNA (0.68) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL3689336 1.00 LMNA (0.68) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL25340521 1.00 LMNA (0.68) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL3088610 1.00 LMNA (0.68) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL20943325 1.00 LMNA (0.68) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL4379473 1.00 LMNA (0.68) LMNAALDH1A1HSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8753686-B2 Surface-treating agents, surface-treated powders, and cosmetics comprising the same SHISEIDO CO., LTD. (JP) 2014-06-17 US disclosed
US-20110280946-A1 Surface-Treating Agents, Surface-Treated Powders, And Cosmetics Comprising The Same SHISEIDO CO., LTD. (JP) 2011-11-17 US disclosed
EP-2112179-B1 Surface-treated powders, and cosmetics comprising the same SHISEIDO CO LTD (JP) 2011-04-27 EP disclosed
US-20100119470-A1 Method Of Reducing The Appearance Of Wrinkles SHISEIDO COMPANY, LTD. (JP) 2010-05-13 US disclosed
EP-1803750-B1 USE OF A POLYMER FOR SURFACE-TREATING A POWDER SHISEIDO CO LTD (JP) 2009-12-09 EP disclosed
EP-2112179-A1 Surface-treated powders, and cosmetics comprising the same Shiseido Co., Ltd. (JP) 2009-10-28 EP disclosed
US-20080081029-A1 acrylic homopolymers or copolymers, that can provide excellent hydrophobicity to powders or cosmetics, and can improve its rinsability SHISEIDO CO., LTD. (JP) 2008-04-03 US disclosed
EP-1803750-A1 SURFACE-TREATING AGENT, SURFACE-TREATED POWDER, AND COSMETIC PREPARATION CONTAINING SAME Shiseido Company, Limited (JP) 2007-07-04 EP disclosed
US-20070148120-A1 Skin preparations for external use for wrinkle reduction SHISEIDO COMPANY LTD. (JP) 2007-06-28 US disclosed
EP-1704849-A1 SKIN PREPARATIONS FOR EXTERNAL USE FOR WRINKLE DIMINUTION SHISEIDO COMPANY, LTD. (JP) 2006-09-27 EP disclosed
CN-1711082-A Novel hydroxyindoles, their use as phosphodiesterase 4 inhibitors and process for their preparation ELBION AG (DE) 2005-12-21 CN disclosed
EP-0389269-B1 DIESTERS AND THEIR USE IN WAXES UNICHEMA CHEMIE B.V. (NL) 1993-05-26 EP disclosed
US-5104586-A Having branched saturated hydrocarbon chains; for cosmetic emulsions UNILEVER PATENT HOLDINGS B.V. (NL) 1992-04-14 US disclosed
EP-0389269-A1 Diesters and their use in waxes UNICHEMA CHEMIE B.V. (NL) 1990-09-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080081029-A1 acrylic homopolymers or copolymers, that can provide excellent hydrophobicity to powders or cosmetics, and can improve its rinsability CHRM1, H1-0, H1-2 LMNA 2921/4885ALDH1A1 142/4885HSD17B10 1723/4885
US-20110280946-A1 Surface-Treating Agents, Surface-Treated Powders, And Cosmetics Comprising The Same CHRM1, H1-0, H1-2 LMNA 1417/4885ALDH1A1 115/4885HSD17B10 2655/4885
US-20070148120-A1 Skin preparations for external use for wrinkle reduction CUTA, MMS19, COL14A1 LMNA 167/4885ALDH1A1 4533/4885HSD17B10 3120/4885
US-20100119470-A1 Method Of Reducing The Appearance Of Wrinkles CUTA, MMS19, COL14A1 LMNA 112/4885ALDH1A1 4489/4885HSD17B10 2167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.